Fig. 1From: A review of Janus kinase inhibitors for the treatment of Covid-19 pneumoniaJAK/STAT signal pathway and its inhibitor. Cytokines and growth factors bind to cell surface receptors and activate the associated JAK-STAT signaling pathwayBack to article page